French startup Cureety, a telemedicine startup that improves the follow-up and care of patients, has announced a fundraising of € 1.2 million, led by five business angels, BPI France and Cureety’s existing partners, Crédit Mutuel Bretagne (CMB) and Crédit Agricole (CA) Bretagne.
The Breton-based startup, founded in 2018, is developing an e-health solution making it possible to remotely monitor and optimize the care of patients with cancer. The tool overall improves the patient journey, as patients become actors in their care journey by regularly reporting the real-time side effects of their treatments, helping healthcare professionals to adjust and optimize treatments. Today, the Cureety device is used (either being adopted or tested) by more than 20 healthcare establishments in France, and has made it possible to initiate active surveillance of more than 2,000 patients.
“This first round of funding allows us to accelerate the deployment of our platform nationally and to continue to enrich our platform with additional and complementary eHealth services in order to offer the most successful digital care pathway to our community, patients and caregivers. The need is even more visible in this pandemic period linked to Covid19, as demonstrated by the rapid adoption by carers and patients of the Cureety solution,” comments François-Guirec Champoiseau, President and co-Founder of Cureety.
“We were very impressed by the ability of the Cureety team to quickly develop a software offer that meets an urgent need to optimize patient care and facilitate the coordination of care between the city and the hospital. The quality and multidisciplinarity of the team, the excellent patient support via the platform, and the relevance of Cureety’s business model, focused on research, are all factors that convinced us to support this project,” adds Alain J. Gilbert, Business Angel, Life Science entrepreneur and member of the Cureety Strategic Committee.
The startup now aims to accelerate the deployment of its system in France, which due to the current pandemic, will be needed more than ever. Europe has seen a boost in investments for telemedicine solutions in the past few weeks, for example in Estonia with Viveo Health, and in France with Wellium.